Morphologic Changes in Ovarian Carcinoma After Neoadjuvant Chemotherapy: Report of a Case Showing Extensive Clear Cell Changes Mimicking Clear Cell Carcinoma

2009 ◽  
Vol 28 (5) ◽  
pp. 442-446 ◽  
Author(s):  
Ivy Chew ◽  
Robert A. Soslow ◽  
Kay J. Park
2015 ◽  
Vol 23 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Luigi Insabato ◽  
Valentina Natella ◽  
Anna Somma ◽  
Marcello Persico ◽  
Luigi Camera ◽  
...  

2019 ◽  
Vol 14 (2) ◽  
pp. 65-66
Author(s):  
Shreena Shrestha ◽  
Ganesh Dangal ◽  
Kabin Bhattachan

Clear cell carcinoma of cervix is a rare neoplasm accounting for round 4% of all adenocarcinomas. It is usually seen in patients with a history of intrauterine exposure to diethylstilbestrol. We are reporting a case of clear cell carcinoma of cervix in a 50 years old P1L1 postmenopausal woman, with no history of exposure to diethylstilbestrol in-utero or synthetic non-steroidal estrogen, and who was managed with neoadjuvant chemotherapy followed by modified radical hysterectomy with pelvic lymphadenectomy and adjuvant chemotherapy.


2012 ◽  
Vol 22 (7) ◽  
pp. 1198-1202 ◽  
Author(s):  
Ali Ayhan ◽  
Polat Dursun ◽  
Burcu Kisa Karakaya ◽  
Ozlem Ozen ◽  
Cagla Tarhan

ObjectiveTo report a triplet pregnancy complicated by clear cell cervical carcinoma that was managed using neoadjuvant chemotherapy followed by caesarean radical hysterectomy.Patient HistoryA 26-year-old woman had a diagnosis of cervical clear cell carcinoma, which was International Federation of Gynecology and Obstetrics stage IB1, at 18 weeks of gestation during a triplet pregnancy. Owing to the patient’s strong desire for full-term pregnancy, 3 cycles of neoadjuvant chemotherapy was administered after magnetic resonance imaging evaluation of the tumor. The patient underwent cesarean delivery and radical hysterectomy at gestational week 32. The hysterectomy specimen revealed stage IB1 clear cell adenocarcinoma of the cervix. The neonates and the mother did not have any complications related to the treatment during 36 months of follow-up.ConclusionTo the best of our knowledge, this is the first report of a triplet pregnancy complicated by cervical clear cell carcinoma that was successfully treated with neoadjuvant chemotherapy and cesarean radical hysterectomy. Our experience and literature review suggest that neoadjuvant chemotherapy for cervical carcinoma diagnosed during pregnancy is associated with excellent oncologic and fetal outcome; therefore, it may be considered as a temporary fertility-sparing approach in selected patients with a strong desire for full-term pregnancy. Nonetheless, additional research and long-term follow-up are needed to reach a more definitive conclusion.


2014 ◽  
Vol 65 (1) ◽  
pp. 90-99 ◽  
Author(s):  
Joo-Yeon Kim ◽  
Do Youn Park ◽  
Gwang Ha Kim ◽  
Tae-Yong Jeon ◽  
Gregory Y Lauwers

2011 ◽  
Vol 24 (8) ◽  
pp. 1139-1145 ◽  
Author(s):  
Elisabetta Kuhn ◽  
Alan K Meeker ◽  
Kala Visvanathan ◽  
Amy L Gross ◽  
Tian-Li Wang ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Yehuda Galili ◽  
Meghan Lytle ◽  
Jonathan Bartolomei ◽  
Kataria Amandeep ◽  
Nichole Allen ◽  
...  

Ovarian clear-cell carcinoma is an uncommon subtype of epithelial ovarian carcinoma. It carries a generally poor prognosis because of its resistance to standard treatment and metastatic spread to vital organs. Metastasis to the breast is rare and bilateral breast metastasis is unreported. A 61-year-old white female with a 5-year status poststandard therapy for stage IC clear-cell ovarian carcinoma presented with widespread metastasis. Tissue analysis revealed ovarian cancer metastasis to the breasts bilaterally. Clinical awareness of this metastatic potential is important when staging and developing a treatment plan for patients with ovarian clear-cell cancer.


2013 ◽  
Vol 13 (2) ◽  
pp. 79-80
Author(s):  
Zane Simtniece ◽  
Gatis Kirsakmens ◽  
Ilze Strumfa ◽  
Andrejs Vanags ◽  
Maris Pavars ◽  
...  

Abstract Here, we report surgical treatment of a patient presenting with pancreatic metastasis (MTS) of renal clear cell carcinoma (RCC) 11 years after nephrectomy. RCC is one of few cancers that metastasise in pancreas. Jaundice, abdominal pain or gastrointestinal bleeding can develop; however, asymptomatic MTS can be discovered by follow-up after removal of the primary tumour. The patient, 67-year-old female was radiologically diagnosed with a clinically silent mass in the pancreatic body and underwent distal pancreatic resection. The postoperative period was smooth. Four months after the surgery, there were no signs of disease progression.


Sign in / Sign up

Export Citation Format

Share Document